National Prostate Health Month

Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate

Retrieved on: 
Thursday, September 28, 2023
Urine, BPH, AUA, LUTS, Urination, Quality of life, Urinary tract infection, American Urological Association, Olympus Corporation, Research, Prostate, National Prostate Health Month, Patient, Physician, Blood, Ageing, Medical imaging

CENTER VALLEY, Pa., Sept. 28, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today that its iTind™ procedure is now included in the American Urological Association (AUA) clinical practice guideline for management of lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), also known as enlarged prostate. The iTind procedure is reflected in the new procedure category, Temporary Implanted Prostatic Devices (TIPD).i The addition of the TIPD category is based on expert opinion reflecting peer-reviewed treatment recommendations and research updates.

Key Points: 
  • The iTind procedure is reflected in the new procedure category, Temporary Implanted Prostatic Devices (TIPD).i The addition of the TIPD category is based on expert opinion reflecting peer-reviewed treatment recommendations and research updates.
  • The minimally invasive iTind procedure involves the placement of a temporarily implanted nitinol device that reshapes the prostatic urethra without burning or cutting out the prostate.
  • "This guidance reflects compelling clinical evidence and positive clinical experience with the iTind procedure."
  • In rare cases, the iTind device may cause urinary tract infection or a sudden difficulty to urinate.

Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch® Prostate Screening Blood Test to Men With Prostate Cancer Risk

Retrieved on: 
Tuesday, September 26, 2023
Oncology, Health, Medical Devices, Health Technology, Other Science, Science, Biotechnology, PROMIS, Journal of Clinical Oncology, United States National Library of Medicine, Prostate, LDT, PMID, BJU International, AIM, National Prostate Health Month, University, Prostate cancer, Abner Doble, Hospital, TRUS, Section, Cancer, UK2, OBD, Large intestine, Mortality, Lung, Penn Presbyterian Medical Center, Protection, MRI, Journal, Patient, Risk, Medicine, BMJ, PSE, Movember, PMCID, NHS, Erectile dysfunction, Death, PSA, News, Biopsy, Dairy, Medical imaging, Urology, Lancet

The current blood screening test, the PSA test, is only 55% accurate, and is considered an unreliable test by many doctors, including the NHS in the UK2.

Key Points: 
  • The current blood screening test, the PSA test, is only 55% accurate, and is considered an unreliable test by many doctors, including the NHS in the UK2.
  • It feels wholly appropriate that the early launch of the test coincides with Prostate Cancer Awareness month," said Dr Jon Burrows, OBD's Chief Executive Officer.
  • Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication, Journal of Clinical Oncology [online], 28:15.
  • Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

THE PROSTATE CANCER FOUNDATION CHALLENGES AMERICA TO GET HEALTHY THIS SEPTEMBER

Retrieved on: 
Thursday, August 31, 2023
Exercise, Epidemiology, Prostate Cancer Foundation, Nutrition, National Prostate Health Month, Prostate cancer, Harvard T.H. Chan School of Public Health, Health, Anxiety, PCF, Revlon Run Walk, Health equity, Cancer, DRS, Research, Prostate, Black, Harvard University, Mental, Addiction medicine, Soho House, Public health, Doctor of Science, MD, Risk, Radio, Relaxation, MPH, PSA, Dairy, Dietary supplement

LOS ANGELES, Aug. 31, 2023 /PRNewswire/ -- September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.

Key Points: 
  • LOS ANGELES, Aug. 31, 2023 /PRNewswire/ -- September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.
  • While eating healthy and exercising can't stop you from getting cancer, research shows that it can lower your risk.
  • They can also create personal Facebook fundraisers to raise funds for prostate cancer research while raising awareness about the benefits of a healthy lifestyle.
  • In addition to the Get Healthy with PCF Challenges, PCF has additional activities planned during Prostate Cancer Awareness Month.

September is Prostate Cancer Awareness Month: Know the Warning Signs, When to Get Screened and Important New Treatments

Retrieved on: 
Wednesday, August 30, 2023
Human, Prostate-specific antigen, Radiation, National Prostate Health Month, Biopsy, Prostate cancer, Survival, Urethra, Urination, Cancer, Breast, Research, Risk, Mortality, Prostate, Immunotherapy, Science, Pain, Death, Incidence, Estate (law), ACS, IMPACT, Blood, Ejaculation, American Cancer Society, Breast cancer, Smoking, White, PSA, Disease, American Cancer Society Cancer Action Network, Dairy, Birth control, Medical imaging

ATLANTA, Aug. 30, 2023 /PRNewswire/ -- Prostate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black men are two times more likely to die from the disease than White men and have the highest death rate for prostate cancer of any racial and ethnic group. However, when prostate cancer is detected early, the odds of survival are high. In fact, more than 3.5 million men diagnosed with the disease in the U.S. are still alive today.

Key Points: 
  • Renowned prostate cancer researcher Dr. Lorelei Mucci is the director of strategic research partnerships at the American Cancer Society.
  • Her role includes leading an ACS initiative called IMPACT , or "Improving Mortality Toward Prostate Cancer Together" to address the alarming negative trends in prostate cancer incidence and disparities.
  • For Prostate Cancer Awareness Month Dr. Mucci reviews the signs and symptoms of prostate cancer, including important information about risk factors, PSA screening, and more:
    1-Why is it important every September during Prostate Cancer Awareness Month to help people learn about the disease?
  • Prostate Cancer Awareness Month is so important to have a focused time for men and their families to share knowledge, experiences, and state of science on this important cancer.

New Research Finds: 61 Per Cent of Canadians Say Their Loved Ones Procrastinate Getting Tested for Prostate Cancer

Retrieved on: 
Wednesday, August 30, 2023
Light Up Night, Manitoba Legislative Building, Prostate Cancer Foundation, Probability, National Prostate Health Month, Prostate cancer, Life, Friends, Shock, Human, Research, Prostate, Black, PCFC, Incidence, Olympic Plaza, The Bridge, City, Patient, Lariviere, Diagnosis, Ageing, Empathy, Town hall, Family, News, Social media, CN Tower, Notre Dame Basilica, Dairy, Birth control, Nursing

"According to loved ones, many men appear to be avoiding facing fears of a worst-case scenario possibly coming true in their lives."

Key Points: 
  • "According to loved ones, many men appear to be avoiding facing fears of a worst-case scenario possibly coming true in their lives."
  • PCFC commissioned this survey among 1,334 Canadians on the Angus Reid Forum in August 2023.
  • It set out to discover how family members encourage the men in their lives to proactively get a prostate cancer screening.
  • Men are putting off testing: The majority of Canadians (63 per cent) believe the man in their life is aware of the benefits of early prostate cancer detection, however 61 per cent say their loved one procrastinates going to get tested.

ZERO Prostate Cancer Promotes Early Detection as a National Priority During Prostate Cancer Awareness Month

Retrieved on: 
Tuesday, August 29, 2023
Risk, National Prostate Health Month, Prostate cancer, Education, Cancer, ZERO, Screening, American Cancer Society, Disease, Dairy

WASHINGTON, Aug. 29, 2023 /PRNewswire/ -- ZERO Prostate Cancer urges men to learn about their prostate cancer risks and early detection during Prostate Cancer Awareness Month, beginning September 1. According to the American Cancer Society, 3.1 million+ men live with prostate cancer, making it the most commonly diagnosed cancer and one of the leading causes of cancer deaths among American men.

Key Points: 
  • WASHINGTON, Aug. 29, 2023 /PRNewswire/ -- ZERO Prostate Cancer urges men to learn about their prostate cancer risks and early detection during Prostate Cancer Awareness Month , beginning September 1.
  • According to the American Cancer Society , 3.1 million+ men live with prostate cancer, making it the most commonly diagnosed cancer and one of the leading causes of cancer deaths among American men.
  • "Prostate Cancer Awareness Month elevates the urgency of early detection.
  • ZERO Prostate Cancer Day will be held on September 28, encouraging donations and sharing of life-saving messages.

Egg Medical Names Gavin Philipps as Global Chief Commercial Officer

Retrieved on: 
Friday, February 10, 2023
MBA, Egg, Organization, Health, Purdue University, Hospital, National Prostate Health Month, OBL, University, Engineering, Boston Scientific, Radiation, Growth, University of North Carolina at Charlotte, Marine Corps Expeditionary Medal, BS, Butterfly network, MD, Management, Sales

ARDEN HILLS, Minn., Feb. 10, 2023 /PRNewswire/ -- Egg Medical, Inc ., a medical technology company committed to reducing scatter radiation exposure during interventional angiographic procedures, is excited to announce that Gavin Philipps will be joining the executive team as the Global Chief Commercial Officer.

Key Points: 
  • ARDEN HILLS, Minn., Feb. 10, 2023 /PRNewswire/ -- Egg Medical, Inc ., a medical technology company committed to reducing scatter radiation exposure during interventional angiographic procedures, is excited to announce that Gavin Philipps will be joining the executive team as the Global Chief Commercial Officer.
  • Gavin brings over 25 years of commercial leadership experience in the medical field in new business development, building go-to-market strategies for new businesses, and building high performing teams.
  • Prior to joining Egg Medical, Gavin served in various executive leadership roles, where he built teams and commercial strategies to help achieve significant growth across companies including Covidien, Boston Scientific, and Butterfly Network.
  • "We are thrilled to have Gavin join Egg Medical.

Myovant Recognizes Prostate Cancer Awareness Month with Educational Sponsorships and Online Campaign to Encourage Patients to Speak Up, Seek Support and Be Informed

Retrieved on: 
Friday, September 16, 2022
Injection, Safety, Awareness, African, Social media, Patient, American Urological Association, Prostate cancer, EC, New Drug Application, Testosterone, Disease, PCIA, Sex, Food, Organization, Pain, Science, Roivant Sciences, Man, Depression, Woman, NYSE, Risk, Prostate-specific antigen, FDA, Medicines and Healthcare products Regulatory Agency, National Prostate Health Month, Review, Uterine fibroid, Pregnancy, Female, MHRA, GLOBE, Endometriosis, RWS, Twitter, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Infertility, LinkedIn, Cancer, Caregiver, LHRH, Education, Recurrence, USPI, Medical imaging, Birth control

BASEL, Switzerland, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences(NYSE:MYOV) today announced an educational campaign to inspire prostate cancer patients to speak up and seek support through authentic conversations, along with the sponsorship of educational opportunities for patients, providers, and caregivers during Prostate Cancer Awareness Month.

Key Points: 
  • BASEL, Switzerland, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences(NYSE:MYOV) today announced an educational campaign to inspire prostate cancer patients to speak up and seek support through authentic conversations, along with the sponsorship of educational opportunities for patients, providers, and caregivers during Prostate Cancer Awareness Month.
  • Studies have repeatedly shown that many patients lack the resources and willingness to speak openly about their condition, and Prostate Cancer Awareness month presents the opportunity to address these findings through increased awareness and education.
  • It will play host to the new video series Men With Prostate Cancer Find Support which illustrates how valuable peer to peer support can be.
  • The videos also link to resources that provide listings of third-party directories for prostate cancer support groups.

This Prostate Cancer Awareness Month, National Nonprofit Urges Early Detection as Key to Survival

Retrieved on: 
Thursday, September 1, 2022
Minter, Strathcona County, Prostate cancer, ZERO, Health equity, CEO, Cancer, Research, Survival rate, Death, Awareness, Solution, Man, SC, National Prostate Health Month, MA, Prostate, White, PCAM, Columbia, Patient, Medical imaging

WASHINGTON, Sept. 1, 2022 /PRNewswire/ --

Key Points: 
  • All month long, the nation's leading nonprofit in the fight against prostate cancer, ZERO - The End of Prostate Cancer , will partner with experts and celebrity spokespersons to raise awareness for the importance of early detection.
  • ZERO is encouraging all men to learn about prostate cancer risks and promote early detection during Prostate Cancer Awareness Month (PCAM), beginning September 1.
  • Black men are almost twice as likely to be diagnosed with prostate cancer and over twice as likely to die from prostate cancer as White men.
  • About ZERO - The End of Prostate Cancer:
    ZERO The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted.

Depend® Brand Champions Third Annual Stand Strong for Men's Health™ Initiative with Brian Austin Green to Benefit the Prostate Cancer Foundation

Retrieved on: 
Thursday, September 1, 2022
Prostate cancer, CEO, Technology, Inflammatory bowel disease, PCF, NYSE, PSA, Research, Huggies, Prostate Cancer Foundation, Disease, Andrex, Survivor, Man, Kleenex, Urinary incontinence, Death, Poise, Awareness, Radiation, VOID, Health, Learning, Diagnosis, Courage, National Prostate Health Month, KMB, Quality of life, No, Multimedia, Creativity, Prostate-specific antigen, Kotex, Men's Light-Contact at WAKO World Championships 2007 Belgrade -63 kg, Education, News, Adult, Prostate, Risk, Huggies Pull-Ups, MS, Association, Men's Health, Kimberly-Clark, PSMA, Ulcerative colitis, Stand Strong Stand Proud, Life, Shoe, Family, Patient, Medical imaging, Pharmaceutical industry, Medical device, Cottonelle, Dependency, GoodNites, Incontinence

NEENAH, Wis., Sept. 1, 2022 /PRNewswire/ -- The Depend® brand is igniting conversations about the importance of men proactively taking charge of their health and championing the strength of those fighting prostate cancer with its third year of the Stand Strong for Men's Health™ initiative, benefiting the Prostate Cancer Foundation (PCF). Beginning in September, Prostate Cancer Awareness Month, Depend® will donate up to $350,0001 toward PCF's work to improve the early detection and treatment of prostate cancer.

Key Points: 
  • Beginning in September, Prostate Cancer Awareness Month, Depend will donate up to $350,0001 toward PCF's work to improve the early detection and treatment of prostate cancer.
  • For father, actor and Depend partner Brian Austin Green , the Stand Strong for Men's Health message is personal.
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research.
  • 5 Depend will donate $0.50 to Prostate Cancer Foundation for each Depend Shields and Depend Real-Fit product purchased in the United States 9/1/2022 11/30/2022.